Company & Sponsor Intelligence

Eisai Inc.

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials19

Recruiting5

Completed9

Countries3

Therapeutic footprint

alzheimersepilepsyneurodevelopmental_otherpain_neuropathyparkinsonssleep_disorders

Indexed studies

NCT03778424An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303
epilepsy · PolandAVAILABLE

NCT00711204Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
alzheimers · United StatesPHASE4

NCT04468659AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
alzheimers · United StatesPHASE3

NCT00368108Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
parkinsons · United StatesPHASE3

NCT03887455A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
alzheimers · United StatesPHASE3

NCT003684724-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures
epilepsy · United StatesPHASE2

NCT00571064The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
alzheimers · United StatesPHASE4

NCT03288129Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
epilepsy · United StatesPHASE4

NCT01393743A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
epilepsy · PHASE3

NCT06602258A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
alzheimers · United StatesPHASE2

NCT07493265A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
sleep_disorders · United StatesPHASE2

NCT00427011A Study of E2007 In Patients With Parkinson's Disease
parkinsons · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →